Narrative review / 2016
A review reports metabolic vitamin B12 deficiency affects 10%-40% of people and is linked to stroke and cognitive decline.
A narrative review notes metabolic vitamin B12 deficiency occurs in 10%-40% of the population and contributes to cognitive decline and stroke in older people. Diagnosing it requires functional markers like holotranscobalamin, methylmalonic acid, or plasma total homocysteine rather than serum B12 alone. Cyanocobalamin reduced stroke risk in individuals with normal renal function but proved harmful in those with renal impairment, while B12 therapy slowed gray matter atrophy and cognitive decline in a cited trial.
- Study type
- Narrative review
- Who was studied
- Older people and individuals with metabolic vitamin B12 deficiency
- What was measured
- Cognitive decline, dementia, and stroke
THE PAPER
Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke.
Spence JD. Nutr Res, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.